These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 33005739)
1. The effect of size, charge, and peptide ligand length on kidney targeting by small, organic nanoparticles. Huang Y; Jiang K; Zhang X; Chung EJ Bioeng Transl Med; 2020 Sep; 5(3):e10173. PubMed ID: 33005739 [TBL] [Abstract][Full Text] [Related]
2. Renal Targeting: Peptide-Based Drug Delivery to Proximal Tubule Cells. Wischnjow A; Sarko D; Janzer M; Kaufman C; Beijer B; Brings S; Haberkorn U; Larbig G; Kübelbeck A; Mier W Bioconjug Chem; 2016 Apr; 27(4):1050-7. PubMed ID: 26999755 [TBL] [Abstract][Full Text] [Related]
3. Heuristics for the Optimal Presentation of Bioactive Peptides on Polypeptide Micelles. Wang J; Saha S; Schaal JL; Yousefpour P; Li X; Chilkoti A Nano Lett; 2019 Nov; 19(11):7977-7987. PubMed ID: 31642326 [TBL] [Abstract][Full Text] [Related]
4. The Weak Link: Optimization of the Ligand-Nanoparticle Interface To Enhance Cancer Cell Targeting by Polymer Micelles. Wang J; Dzuricky M; Chilkoti A Nano Lett; 2017 Oct; 17(10):5995-6005. PubMed ID: 28853896 [TBL] [Abstract][Full Text] [Related]
6. In vitro delivery of mTOR inhibitors by kidney-targeted micelles for autosomal dominant polycystic kidney disease. Cox A; Tung M; Li H; Hallows KR; Chung EJ SLAS Technol; 2023 Aug; 28(4):223-229. PubMed ID: 36804177 [TBL] [Abstract][Full Text] [Related]
7. A positron emission tomography image-guidable unimolecular micelle nanoplatform for cancer theranostic applications. Yang J; Lu W; Xiao J; Zong Q; Xu H; Yin Y; Hong H; Xu W Acta Biomater; 2018 Oct; 79():306-316. PubMed ID: 30172067 [TBL] [Abstract][Full Text] [Related]
8. Improving kidney targeting: The influence of nanoparticle physicochemical properties on kidney interactions. Huang Y; Wang J; Jiang K; Chung EJ J Control Release; 2021 Jun; 334():127-137. PubMed ID: 33892054 [TBL] [Abstract][Full Text] [Related]
9. In vivo biodistribution and clearance of peptide amphiphile micelles. Chung EJ; Mlinar LB; Sugimoto MJ; Nord K; Roman BB; Tirrell M Nanomedicine; 2015 Feb; 11(2):479-87. PubMed ID: 25194999 [TBL] [Abstract][Full Text] [Related]
10. Investigation of Basolateral Targeting Micelles for Drug Delivery Applications in Polycystic Kidney Disease. Huang Y; Osouli A; Pham J; Mancino V; O'Grady C; Khan T; Chaudhuri B; Pastor-Soler NM; Hallows KR; Chung EJ Biomacromolecules; 2024 May; 25(5):2749-2761. PubMed ID: 38652072 [TBL] [Abstract][Full Text] [Related]
11. Fibrin-binding, peptide amphiphile micelles for targeting glioblastoma. Chung EJ; Cheng Y; Morshed R; Nord K; Han Y; Wegscheid ML; Auffinger B; Wainwright DA; Lesniak MS; Tirrell MV Biomaterials; 2014 Jan; 35(4):1249-56. PubMed ID: 24211079 [TBL] [Abstract][Full Text] [Related]
12. Shape Effects of Peptide Amphiphile Micelles for Targeting Monocytes. Joo J; Poon C; Yoo SP; Chung EJ Molecules; 2018 Oct; 23(11):. PubMed ID: 30373234 [TBL] [Abstract][Full Text] [Related]
13. Oral delivery of nanomedicine for genetic kidney disease. Huang Y; Wang J; Mancino V; Pham J; O'Grady C; Li H; Jiang K; Chin D; Poon C; Ho PY; Gyarmati G; Peti-Peterdi J; Hallows KR; Chung EJ PNAS Nexus; 2024 May; 3(5):pgae187. PubMed ID: 38807632 [TBL] [Abstract][Full Text] [Related]
14. Gadolinium-Functionalized Peptide Amphiphile Micelles for Multimodal Imaging of Atherosclerotic Lesions. Yoo SP; Pineda F; Barrett JC; Poon C; Tirrell M; Chung EJ ACS Omega; 2016 Nov; 1(5):996-1003. PubMed ID: 27917409 [TBL] [Abstract][Full Text] [Related]
15. Hybrid, metal oxide-peptide amphiphile micelles for molecular magnetic resonance imaging of atherosclerosis. Poon C; Gallo J; Joo J; Chang T; Bañobre-López M; Chung EJ J Nanobiotechnology; 2018 Nov; 16(1):92. PubMed ID: 30442135 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic Analysis of Peptide-Modified Nanoparticles with Engineered Physicochemical Properties in a Mouse Model of Traumatic Brain Injury. Waggoner LE; Madias MI; Hurtado AA; Kwon EJ AAPS J; 2021 Aug; 23(5):100. PubMed ID: 34401968 [TBL] [Abstract][Full Text] [Related]
17. Surface-adaptive zwitterionic nanoparticles for prolonged blood circulation time and enhanced cellular uptake in tumor cells. Ou H; Cheng T; Zhang Y; Liu J; Ding Y; Zhen J; Shen W; Xu Y; Yang W; Niu P; Liu J; An Y; Liu Y; Shi L Acta Biomater; 2018 Jan; 65():339-348. PubMed ID: 29079515 [TBL] [Abstract][Full Text] [Related]
18. Transdermal Delivery of Kidney-Targeting Nanoparticles Using Dissolvable Microneedles. Tripathy N; Wang J; Tung M; Conway C; Chung EJ Cell Mol Bioeng; 2020 Oct; 13(5):475-486. PubMed ID: 33184578 [TBL] [Abstract][Full Text] [Related]
19. Octreotide-functionalized and resveratrol-loaded unimolecular micelles for targeted neuroendocrine cancer therapy. Xu W; Burke JF; Pilla S; Chen H; Jaskula-Sztul R; Gong S Nanoscale; 2013 Oct; 5(20):9924-33. PubMed ID: 23986296 [TBL] [Abstract][Full Text] [Related]
20. Delivery of sorafenib by myofibroblast-targeted nanoparticles for the treatment of renal fibrosis. Cheng HT; Huang HC; Lee TY; Liao YH; Sheng YH; Jin PR; Huang KW; Chen LH; Chen YT; Liu ZY; Lin TC; Wang HC; Chao CH; Juang IP; Su CT; Huang KH; Lin SL; Wang J; Sung YC; Chen Y J Control Release; 2022 Jun; 346():169-179. PubMed ID: 35429575 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]